American International Group, Inc. Century Therapeutics, Inc. Transaction History

American International Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.19 - $5.32 $319 - $532	-100 Reduced 0.86%	11,543 $48,000
Q4 2023 Feb 13, 2024	SELL	$1.28 - $3.32 $58 - $152	-46 Reduced 0.39%	11,643 $38,000
Q3 2023 Nov 13, 2023	BUY	$2.0 - $3.23 $832 - $1,343	416 Added 3.69%	11,689 $23,000
Q2 2023 Aug 04, 2023	BUY	$2.91 - $3.53 $4,522 - $5,485	1,554 Added 15.99%	11,273 $35,000
Q1 2023 May 12, 2023	BUY	$3.4 - $5.11 $656 - $986	193 Added 2.03%	9,719 $33,000
Q4 2022 Feb 10, 2023	SELL	$4.84 - $11.58 $169 - $405	-35 Reduced 0.37%	9,526 $48,000
Q3 2022 Nov 14, 2022	BUY	$8.57 - $13.1 $1,165 - $1,781	136 Added 1.44%	9,561 $95,000
Q2 2022 Aug 12, 2022	BUY	$7.96 - $12.43 $6,535 - $10,205	821 Added 9.54%	9,425 $79,000
Q1 2022 May 13, 2022	BUY	$11.62 - $15.92 $27,051 - $37,061	2,328 Added 37.09%	8,604 $108,000
Q4 2021 Feb 11, 2022	SELL	$13.93 - $23.62 $2,604 - $4,416	-187 Reduced 2.89%	6,276 $100,000
Q3 2021 Nov 12, 2021	BUY	$20.8 - $31.93 $134,430 - $206,363	6,463 New	6,463 $163,000

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $74.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.